Here's what to expect from the Australian-based global biotechnology company this year. The post Prediction: CSL shares could ...

CSL Ltd (ASX: CSL) shares slumped in 2025, but the outlook may be improving. Here’s why I think CSL could beat the ASX 200 ...

CSL Limited, a biotechnology company that produce many of its biological products from plasma, is diversifying its portfolio and its drug pipeline through its largest ever acquisition: the purchase of ...

CSL Ltd (ASX: CSL) shares were sold off in 2025. Let's find out why and see if this is a buying opportunity for ...

Though the setbacks by the Chinese national team have cast a shadow over domestic football, this season's Chinese Super League (CSL) is enjoying a vibrant renaissance powered by packed stadiums and ...

Health editor Michael Smith on CSL’s remarkable story, why investors have fallen out of love with the healthcare giant and what Trump has to do with it. CSL was run like a bureaucracy until 1990 when ...